Bioscribe is an independent consultancy dedicated to supporting the communications goals of life science organizations. We specialize in smart and savvy strategic counseling, public relations, and marketing communications for omics tools and software companies, and professional organizations.

Since 1997, Bioscribe's consultants have offered clients targeted, high quality and integrated communications services designed to meet and exceed corporate and marketing objectives. We work with small start-ups, mid-sized companies, and Fortune 500 companies, as well as non-profits.

We help our clients define their messaging and positioning, identify publicity opportunities, manage their day-to-day corporate and product news flow, and get media coverage.

Areas of Expertise:

• Developing strategic and tactical public relations and marketing communications plans
• Managing public relations initiatives and marketing communications programs
• Writing and producing promotional materials, including press releases, brochures, by-lined articles, white papers, and websites 
• Media relations, including pitching news and feature stories, placing by-lined articles, and preparing spokespersons for interviews

Bioscribe has thrived due to happy, repeat customers and referrals from these clients. 

To learn more about what we can do for you, contact us at info@bioscribe.com 



Bioscribe Clients in the News:

Top 10 Biotech Techies list features DNAnexus CEO & PacBio CSO | FierceBiotech IT 

Interview with PaxVax CEO |BIO Buzz

Former Senior FBI Official Joins IntegenX | Forensic Magazine

RainDance Launches DIgital PCR Platform; Claims Sensitivity, Operating Cost Superiority | PCR Insider

PaxVax Preps Cholera Vaccine For Phase III; H5N1 for Phase II | BioWorld

The Human Genome, Sequenced: Predicting the Future of DNA Tech | The Atlantic

After a Year of Testing, Two Early PacBio Customers Expect More Routine Use of RS Sequencer in 2012 | GenomeWeb

RainDance ThunderStorm System Named a Top 10 Innovation of 2011 | The Scientist

NanoString Nails Breast Cancer Study, Challenging Genomic Health | Xconomy

DNA Sequencing Caught in Deluge of Data | New York Times

A Tragic Case and A Genomic Hope | Forbes

Taming a Data Storm | San Francisco Business Times